Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
12/31/2009 | US20090325990 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
12/31/2009 | US20090325955 Gyrase inhibitors and uses thereof |
12/31/2009 | US20090325951 Thienyl-and furanyl-isoquinolinones and methods for using them |
12/31/2009 | US20090325935 Gyrase inhibitors and uses thereof |
12/31/2009 | US20090325927 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
12/31/2009 | US20090325228 Fungal cell wall synthesis gene |
12/31/2009 | US20090324672 Poly(Ester-Amide) And Poly(Amide) Coatings For Implantable Medical Devices For Controlled Release Of A Protein Or Peptide And A Hydrophobic Drug |
12/31/2009 | US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
12/30/2009 | WO2009158011A1 Alkynyl alcohols as kinase inhibitors |
12/30/2009 | WO2009157418A1 Carboxylic acid compound |
12/30/2009 | EP2138499A1 Method for manufacturing high purity benzazepin derivatives |
12/30/2009 | EP2138496A1 Antitumoral analogs of lamellarins |
12/30/2009 | EP2137192A1 Derivatives of galantamine as pro-drugs for the treatment of human brain diseases |
12/30/2009 | EP2137182A1 Combination of a narcotic and a non-narcotic analgesic |
12/30/2009 | EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
12/30/2009 | CA2728767A1 Alkynyl alcohols as kinase inhibitors |
12/30/2009 | CA2727340A1 Carboxylic acid compound |
12/29/2009 | USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases |
12/29/2009 | US7638625 Crystalline compounds |
12/29/2009 | US7638546 Imidazolyl derivatives |
12/29/2009 | US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders |
12/29/2009 | US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents |
12/29/2009 | US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
12/29/2009 | US7638527 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |
12/29/2009 | CA2563761C Inhibitors of the hiv integrase enzyme |
12/29/2009 | CA2429440C Dehalogeno-compounds |
12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
12/24/2009 | US20090318529 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells |
12/24/2009 | US20090318475 Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof |
12/23/2009 | WO2009153897A1 Stemonamide synthesis intermediate and pharmaceutical composition for prevention and/or treatment of cancer |
12/23/2009 | EP2134720A1 Heterocyclic spiro-compounds |
12/23/2009 | EP2134681A1 Trans-annular rearrangement of active lactames |
12/23/2009 | EP1483251B1 C3-cyano epothilone derivatives |
12/23/2009 | CN101611025A 5,6-ring annulated indole derivatives and methods of use thereof |
12/23/2009 | CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections |
12/23/2009 | CN101607958A Quinazoline compounds |
12/23/2009 | CN100572360C Isoquinoline compound and its salt preparation method and application |
12/23/2009 | CA2727928A1 Inhibitors of janus kinases |
12/22/2009 | US7635712 Salinosporamides and methods for use thereof |
12/22/2009 | US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease |
12/22/2009 | US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
12/22/2009 | US7635693 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof |
12/22/2009 | CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
12/22/2009 | CA2362381C Amide compounds and medicinal use thereof |
12/22/2009 | CA2345297C Synthetic analogs of ecteinascidin-743 |
12/22/2009 | CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
12/17/2009 | WO2009152200A1 Tricyclic indole derivatives and methods of use thereof |
12/17/2009 | WO2009150318A1 Novel 2-substituted quinoline derivatives, and method for preparing same |
12/17/2009 | US20090312554 Novel Process for the Preparation of Hexacyclic Compounds |
12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
12/17/2009 | US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates |
12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
12/17/2009 | US20090312357 Rifaximin |
12/17/2009 | CA2727620A1 Tricyclic indole derivatives and methods of use thereof |
12/16/2009 | EP2133340A1 Novel benzazepine derivatives |
12/16/2009 | CN101605795A Tricyclic compound and medical use thereof |
12/16/2009 | CN101605794A Aza-benzofuranyl compounds and methods of use |
12/16/2009 | CN101602767A Preparation method of galanthamine |
12/16/2009 | CN100569778C Rifabutin crystallization technique |
12/16/2009 | CN100569777C Method of liquid membrane separation for extracting alkaloid of Macleaya cordata |
12/16/2009 | CN100569769C Compounds with antibacterial activity |
12/15/2009 | US7632955 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
12/15/2009 | US7632946 ethyl 1-(2,4-dimethoxybenzyl)-7-(2-(S)-hydroxymethyl-pyrrolidin-1-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate; 7-(2-aminomethylpyrrolidin-1-yl)-1-(2,4-dimethoxybenzyl)-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-caboxylic acid; treating quinolone-resistant bacterial infections in a mammal |
12/15/2009 | US7632830 Lactam compounds and pharmaceutical use thereof |
12/15/2009 | CA2502264C N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
12/10/2009 | WO2009148654A2 Cephalotaxus esters, methods of synthesis, and uses thereof |
12/10/2009 | WO2009148062A1 Polycyclic compound and organic electroluminescent device using the same |
12/10/2009 | WO2009148016A1 Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound |
12/10/2009 | WO2009148015A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound |
12/10/2009 | WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
12/10/2009 | US20090306396 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
12/10/2009 | US20090306387 Method of manufacturing of 7-ethyl-10-hydroxycamptothecin |
12/10/2009 | US20090306169 Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors |
12/10/2009 | US20090306134 Muscarinic receptor antagonists |
12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
12/10/2009 | US20090306082 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
12/10/2009 | US20090306041 Inhibitors of Bruton's tyrosine kinase |
12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
12/10/2009 | US20090305410 Fluorescent compounds |
12/10/2009 | US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors |
12/10/2009 | CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
12/09/2009 | EP2129677A1 Heterocyclic cyclopamine analogs and methods of use thereof |
12/09/2009 | EP2129224A1 5,6-dihydro-1h-pyridin-2-one compounds |
12/09/2009 | EP1692140B1 Compositions useful as inhibitors of protein kinases |
12/09/2009 | EP1443933B1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
12/09/2009 | CN101600720A Phosphoinositide 3-kinase inhibitor compounds and methods of use |
12/09/2009 | CN101600703A Dispiro tetraoxane compounds |
12/09/2009 | CN101597295A Method for directly extracting camptothecin from mappia foetida |
12/09/2009 | CN100567302C Production of 7-ethyl-camptothecin |
12/09/2009 | CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives |
12/09/2009 | CA2634513A1 Novel intermediate compounds and processes for their preparation |
12/08/2009 | US7629468 Neuroprotectants, analgesics or anticonvulsants |
12/08/2009 | CA2482311C Furyl compounds |
12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
12/08/2009 | CA2388475C Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives |
12/08/2009 | CA2374898C Pyrazinyl-piperazine compounds, their use and preparation |
12/08/2009 | CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
12/03/2009 | WO2009145282A1 Production method for camptothecin derivative |